The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 191, Issue 1-2, 2007, Pages 16-25

  Willenborg, David O ^a   Staykova, Maria ^a   Fordham, Sue ^a   O'Brien, Nikki ^a   Linares, David ^a  

^a The Australian National University   (Australia)

Author keywords

EAE; Interferon gamma; Nitric oxide; Regulation

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLERGIC ENCEPHALOMYELITIS; BIOLOGICAL ACTIVITY; CELL MIGRATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DOWN REGULATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; BRAIN; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, INTERFERON; SEX CHARACTERISTICS; T-LYMPHOCYTES;

EID: 35848956116     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.007     Document Type: Review

References (80)

1. Bebo Jr. B.F., Lee C.H., Orr E.L., and Linthicum D.S. Mast cell-derived histamine and tumour necrosis factor: differences between SJL/J and BALB/c inbred strains of mice. Immunol. Cell Biol. 74 (1996) 225-230
2. Beckman J.S. Protein tyrosine nitration and peroxynitrite. FASEB J. 16 (2002) 1144
3. Bogdan C. The multiplex function of nitric oxide in (auto)immunity. J. Exp. Med. 187 (1998) 1361-1365
4. Bogle R.G., MacAllister R.J., Whitley G.S., and Vallance P. Induction of NG-monomethyl-l-arginine uptake: a mechanism for differential inhibition of NO synthases?. Am. J. Physiol. 269 (1995) C750-C756
5. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 682-685
6. Busconi L., and Michel T. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268 (1993) 8410-8413
7. Busse R., and Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265 (1990) 133-136
8. Cautain B., Damoiseaux J., Bernard I., Fournie E., van Breda Vriesman P., Druet P., and Saoudi A. Non-MHC determined resistance of Brown-Norway rats to develop experimental allergic encephalomyelitis is mediated by the endogenous production of transforming growth factor-beta. Transplant. Proc. 31 (1999) 1602-1603
9. Cautain B., Damoiseaux J., Bernard I., van Straaten H., van Breda Vriesman P., Boneu B., Druet P., and Saoudi A. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 31 (2001) 1132-1140
10. Cautain B., Damoiseaux J., Bernard I., Xystrakis E., Fournie E., van Breda Vriesman P., Druet P., and Saoudi A. The CD8 T cell compartment plays a dominant role in the deficiency of Brown-Norway rats to mount a proper type 1 immune response. J. Immunol. 168 (2002) 162-170
11. Clancy R.M., Leszczynska-Piziak J., and Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90 (1992) 1116-1121
12. Cowden W.B., Cullen F.A., Staykova M.A., and Willenborg D.O. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88 (1998) 1-8
13. Cross A.H., Ramsbottom M.J., and Lyons J.A. NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 173 (2006) 79-86
14. Cua D.J., Hinton D.R., Kirkman L., and Stohlman S.A. Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur. J. Immunol. 25 (1995) 2318-2324
15. Deakin A.M., Payne A.N., Whittle B.J., and Moncada S. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 7 (1995) 408-416
16. Dustin M.L., and Chan A.C. Signaling takes shape in the immune system. Cell 103 (2000) 283-294
17. Ellis T.N., and Beaman B.L. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 112 (2004) 2-12
18. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., and Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160 (1998) 2940-2946
19. Forstermann U., Gath I., Schwarz P., Closs E.I., and Kleinert H. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol. 50 (1995) 1321-1332
20. Friedl P., Entschladen F., Conrad C., Niggemann B., and Zanker K.S. CD4 + T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize beta1 integrin-independent strategies for polarization, interaction with collagen fibers and locomotion. Eur. J. Immunol. 28 (1998) 2331-2343
21. Friedl P., Borgmann S., and Brocker E.B. Amoeboid leukocyte crawling through extracellular matrix: lessons from the Dictyostelium paradigm of cell movement. J. Leukoc. Biol. 70 (2001) 491-509
22. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6 (2007) 169-175
23. Gasperini S., Marchi M., Calzetti F., Laudanna C., Vicentini L., Olsen H., Murphy M., Liao F., Farber J., and Cassatella M.A. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162 (1999) 4928-4937
24. Gasser D.L., Palm J., and Gonatas N.K. Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats. J. Immunol. 115 (1975) 431-433
25. Guo F.H., De Raeve H.R., Rice T.W., Stuehr D.J., Thunnissen F.B., and Erzurum S.C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7809-7813
26. Happ M.P., Wettstein P., Dietzschold B., and Heber-Katz E. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J. Immunol. 141 (1988) 1489-1494
27. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
28. Heneka M.T., and Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114 (2001) 8-18
29. Hibbs Jr. J.B., Taintor R.R., Vavrin Z., and Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157 (1988) 87-94
30. Howard T.H., and Oresajo C.O. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils. J. Cell Biol. 101 (1985) 1078-1085
31. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., and Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 (1993) 1273-1286
32. Ialenti A., Ianaro A., Moncada S., and Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211 (1992) 177-182
33. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 9265-9269
34. Issazadeh S., Kjellen P., Olsson T., Mustafa M., and Holmdahl R. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur. J. Immunol. 27 (1997) 1584-1587
35. Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., and Bloch K.D. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267 (1992) 14519-14522
36. Kanner J., Harel S., and Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27 (1992) 46-49
37. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4651-4655
38. Lamas S., Perez-Sala D., and Moncada S. Nitric oxide: from discovery to the clinic. Trends Pharmacol. Sci. 19 (1998) 436-438
39. Lee S.C., and Brosnan C.F. Cytokine regulation of iNOS expression in human glial cells. Methods 10 (1996) 31-37
40. Levine S., and Sowinski R. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J. Immunol. 114 (1975) 597-601
41. Linares D., Taconis M., Mana P., Correcha M., Fordham S., Staykova M., and Willenborg D.O. Neuronal nitric oxide synthase plays a key role in CNS demyelination. J. Neurosci. 26 (2006) 12672-12681
42. Lowenstein C.J., and Snyder S.H. Nitric oxide, a novel biologic messenger. Cell 70 (1992) 705-707
43. MacMicking J.D., Willenborg D.O., Weidemann M.J., Rockett K.A., and Cowden W.B. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176 (1992) 303-307
44. Madison D.V. Pass the nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4329-4331
45. Marletta M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268 (1993) 12231-12234
46. Martin E., Nathan C., and Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180 (1994) 977-984
47. Moncada S., and Higgs E.A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Investig. 21 (1991) 361-374
48. Moncada S., and Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9 (1995) 1319-1330
49. Mulligan M.S., Hevel J.M., Marletta M.A., and Ward P.A. Tissue injury caused by deposition of immune complexes is l-arginine dependent. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6338-6342
50. Nathan C.F., and Hibbs Jr. J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3 (1991) 65-70
51. O'Brien N.C., Charlton B., Cowden W.B., and Willenborg D.O. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J. Immunol. 163 (1999) 6841-6847
52. Padgett E.L., and Pruett S.B. Rat, mouse and human neutrophils stimulated by a variety of activating agents produce much less nitrite than rodent macrophages. Immunology 84 (1995) 135-141
53. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
54. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 (2005) 1133-1141
55. Peers S.H., Duncan G.S., Flower R.J., and Bolton C. Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat. Int. Arch. Allergy Immunol. 106 (1995) 20-24
56. Pilz R.B., Suhasini M., Idriss S., Meinkoth J.L., and Boss G.R. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9 (1995) 552-558
57. Reiling N., Ulmer A.J., Duchrow M., Ernst M., Flad H.D., and Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24 (1994) 1941-1944
58. Reis L.F., Ruffner H., Stark G., Aguet M., and Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J. 13 (1994) 4798-4806
59. Sahrbacher U.C., Lechner F., Eugster H.P., Frei K., Lassmann H., and Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28 (1998) 1332-1338
60. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7240-7244
61. Sanchez-Madrid F., and del Pozo M.A. Leukocyte polarization in cell migration and immune interactions. EMBO J. 18 (1999) 501-511
62. Sessa W.C., Barber C.M., and Lynch K.R. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ. Res. 72 (1993) 921-924
63. Shiraishi A., Dudler J., and Lotz M. The role of IFN regulatory factor-1 in synovitis and nitric oxide production. J. Immunol. 159 (1997) 3549-3554
64. Smith M.E., Eller N.L., McFarland H.F., Racke M.K., and Raine C.S. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Am. J. Pathol. 155 (1999) 1147-1161
65. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
66. Staykova M.A., Cowden W., and Willenborg D.O. Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation. Immunol. Cell Biol. 80 (2002) 188-197
67. Staykova M.A., Berven L.A., Cowden W.B., Willenborg D.O., and Crouch M.F. Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro trans-endothelial migration in a p70S6 kinase-independent manner. FASEB J. 17 (2003) 1337-1339
68. Staykova M.A., Paridaen J.T., Cowden W.B., and Willenborg D.O. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol. 166 (2005) 147-157
69. Staykova M.A., Fordham S.A., Bartell G.J., Cowden W.B., and Willenborg D.O. Nitric oxide contributes to the resistance of young SJL/J mice to experimental autoimmune encephalomyelitis. J. Neuroimmunol. 176 (2006) 1-8
70. Stuehr D.J., and Griffith O.W. Mammalian nitric oxide synthases. Adv. Enzymol. Relat. Areas Mol. Biol. 65 (1992) 287-346
71. Stuehr D.J., and Marletta M.A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J. Immunol. 139 (1987) 518-525
72. Tada Y., Ho A., Matsuyama T., and Mak T.W. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J. Exp. Med. 185 (1997) 231-238
73. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 2046-2050
74. Vodovotz Y., Kwon N.S., Pospischil M., Manning J., Paik J., and Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J. Immunol. 152 (1994) 4110-4118
75. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., and Cowden W.B. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163 (1999) 5278-5286
76. Willenborg D.O., Staykova M.A., and Cowden W.B. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J. Neuroimmunol. 100 (1999) 21-35
77. Williams R.M., and Moore M.J. Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J. Exp. Med. 138 (1973) 775-783
78. Witowski J., Pawlaczyk K., Breborowicz A., Scheuren A., Kuzlan-Pawlaczyk M., Wisniewska J., Polubinska A., Friess H., Gahl G.M., Frei U., and Jorres A. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165 (2000) 5814-5821
79. Witowski J., Ksiazek K., and Jorres A. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 61 (2004) 567-579
80. Xie Q., and Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 56 (1994) 576-582